| AMVYX | VMVAX | AMVYX / VMVAX | |
| Total Expense Ratio | 0.62 | 0.07 | 886% |
| Annual Report Gross Expense Ratio | 0.62 | 0.07 | 886% |
| Fund Existence | 9 years | 14 years | - |
| Gain YTD | 7.388 | 7.653 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.39B | 31.8B | 20% |
| Annual Yield % from dividends | 1.84 | 2.20 | 84% |
| Returns for 1 year | -3.35 | 1.67 | -201% |
| Returns for 3 years | 5.84 | 26.80 | 22% |
| Returns for 5 years | 9.59 | 54.82 | 17% |
| Returns for 10 years | N/A | 103.36 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PIBQX | 19.61 | -0.20 | -1.01% |
| PGIM Balanced R6 | |||
| LRSYX | 20.31 | -0.31 | -1.50% |
| Lord Abbett Small Cap Value I | |||
| VMGIX | 110.03 | -2.76 | -2.45% |
| Vanguard Mid-Cap Growth Index Investor | |||
| FKAIX | 53.15 | -1.52 | -2.78% |
| Federated Hermes Kaufmann Small Cap IS | |||
| APGRX | 21.52 | -0.70 | -3.15% |
| Yorktown Growth Institutional | |||